Ramos, M.C. de A. et al. 2018. Cost effectiveness of the cancer prevention program for carriers of the BRCA1/2 mutation. Revista de Saúde Pública. 52, (Nov. 2018), 94. DOI:https://doi.org/10.11606/S1518-8787.2018052000643.